  | Boemer, F., Hovhannesyan, K., Piazzon, F., MINNER, F., Mni, M., Jacquemin, V., Mashhadizadeh, D., BENMHAMMED, N., Bours, V., Jacquinet, A., Harvengt, J., Bulk, S., Dideberg, V., Helou, L., Palmeira, L., Dangouloff, T., BabyDetect Expert Panel, & Servais, L. (2025). Population-based, first-tier genomic newborn screening in the maternity ward. Nature Medicine. doi:10.1038/s41591-024-03465-x  Peer Reviewed verified by ORBi |
 | Becker, M. M., Nardes, F., Dangouloff, T., Servais, L., Araujo, A. P. D. Q. C., & Gurgel-Giannetti, J. (October 2024). Why should a 5q spinal muscular atrophy neonatal screening program be started? Arquivos de Neuro-Psiquiatria, 82 (10), 1 - 9. doi:10.1055/s-0044-1791201 Peer Reviewed verified by ORBi |
 | Dangouloff, T., Hovhannesyan, K., Mashhadizadeh, D., MINNER, F., Mni, M., Helou, L., Piazzon, F., Palmeira, L., Boemer, F., & Servais, L. (30 July 2024). Feasibility and Acceptability of a Newborn Screening Program Using Targeted Next-Generation Sequencing in One Maternity Hospital in Southern Belgium. Children, 11 (8), 926. doi:10.3390/children11080926 Peer Reviewed verified by ORBi |
  | Dangouloff, T., Thokala, P., Stevenson, M. D., Deconinck, N., D'Amico, A., Daron, A., DELSTANCHE, S., Servais, L., & Hiligsmann, M. (02 January 2024). Cost-effectiveness of spinal muscular atrophy newborn screening based on real-world data in Belgium. Neuromuscular Disorders, 34, 61-67. doi:10.1016/j.nmd.2023.11.013 Editorial reviewed |
 | Tychon, C., BENMHAMMED, N., Daron, A., Deconinck, N., Dontaine, P., Boemer, F., Servais, L., & Dangouloff, T. (2024). Follow-up of SMA children identified by newborn screening in southern Belgium [Paper presentation]. 52nd Congress of the BVK-SBP, Anvers, Belgium. Editorial reviewed |
 | Mouraux, C., Dangouloff, T., Poleur, M., Mackels, L., Vanden Brande, L., Daron, A., Servais, L., Maertens de Noordhout, A., & DELSTANCHE, S. (2024). Epidemiological study and diagnostic approach analysis of Neuromuscular population of Neuromuscular Reference Center of Liege, Belgium [Poster presentation]. BeSHG annual symposium 2024, Belgium. Peer reviewed |
 | Abiusi, E., Costa-Roger, M., Bertini, E. S., Tiziano, F. D., Tizzano, E. F., SMN2 Study group, Abiusi, E., Baranello, G., Bertini, E., Boemer, F., Burghes, A., Codina-Solà, M., Costa-Roger, M., Dangouloff, T., Groen, E., Gos, M., Jędrzejowska, M., Kirschner, J., Lemmink, H. H., ... Wirth, B. (January 2024). 270th ENMC International Workshop: Consensus for SMN2 genetic analysis in SMA patients 10-12 March, 2023, Hoofddorp, the Netherlands. Neuromuscular Disorders, 34, 114 - 122. doi:10.1016/j.nmd.2023.12.008 Peer Reviewed verified by ORBi |
 | Aragon-Gawinska, K., Mouraux, C., Dangouloff, T., & Servais, L. (29 June 2023). Spinal Muscular Atrophy Treatment in Patients Identified by Newborn Screening-A Systematic Review. Genes, 14 (7), 1377. doi:10.3390/genes14071377 Peer Reviewed verified by ORBi |
 | Dangouloff, T., MOURAUX, C., Piazzon, F., Mashhadizadeh, D., Hovhannesyan, K., Helou, L., Palmeira, L., Boemer, F., & Servais, L. (2023). Dépistage génétique néonatal universel de 126 maladies précoces et traitables : premiers résultats du projet Babydetect [Poster presentation]. 33e Séminaire de Génétique Clinique, Angers, France. Peer reviewed |
 | Dangouloff, T. (2022). Analyse médico-économique du dépistage néonatal de l’amyotrophie spinale en Fédération Wallonie-Bruxelles [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/296328 |
 | Dangouloff, T., Hiligsmann, M., Deconinck, N., D'Amico, A., Seferian, A. M., Boemer, F., & Servais, L. (2022). Financial cost and quality of life of patients with spinal muscular atrophy identified by symptoms or newborn screening. Developmental Medicine and Child Neurology. doi:10.1111/dmcn.15286 Peer Reviewed verified by ORBi |
 | Dangouloff, T., & Servais, L. (2022). Dépistage et traitement de l’amyotrophie spinale. Percentile. Editorial reviewed |
 | BECKERS, P., CABERG, J.-H., DIDEBERG, V., Dangouloff, T., den Dunnen, J. T., BOURS, V., Servais, L., & BOEMER, F. (04 February 2021). Newborn screening of duchenne muscular dystrophy specifically targeting deletions amenable to exon‑skipping therapy. Scientific Reports, 11, 3011. doi:10.1038/s41598-021-82725-z Peer Reviewed verified by ORBi |
 | Dangouloff, T., Boemer, F., & Servais, L. (2021). Newborn screening of neuromuscular diseases. Neuromuscular Disorders. doi:10.1016/j.nmd.2021.07.008 Peer Reviewed verified by ORBi |
 | BOEMER, F., Caberg, J.-H., Beckers, P., Dideberg, V., di Fiore, S., Bours, V., Marie, S., Dewulf, J., Marcelis, L., Deconinck, N., Daron, A., Blasco-Perez, L., Tizzano, E., Hiligsmann, M., Lombet, J., Pereira, T., Lopez-Granados, L., Shalchian-Tehran, S., van Assche, V., ... Servais, L. (2021). Three years pilot of spinal muscular atrophy newborn screening turned into official program in Southern Belgium. Scientific Reports, 11 (1), 19922. doi:10.1038/s41598-021-99496-2 Peer Reviewed verified by ORBi |
 | Dangouloff, T., Botty, C., Beaudart, C., Servais, L., & Hiligsmann, M. (January 2021). Systematic literature review of the economic burden of spinal muscular atrophy and economic evaluations of treatments. Orphanet Journal of Rare Diseases, 16 (1), 47. doi:10.1186/s13023-021-01695-7 Peer Reviewed verified by ORBi |
 | Dangouloff, T., Vrščaj, E., Servais, L., & Osredkar, D. (2021). Newborn screening programs for spinal muscular atrophy worldwide: where we stand and where to go. Neuromuscular Disorders, 31 (6), 574 - 582. doi:10.1016/j.nmd.2021.03.007 Peer Reviewed verified by ORBi |
 | BECKERS, P., CABERG, J.-H., DIDEBERG, V., Dangouloff, T., den Dunnen, J. T., BOURS, V., Servais, L., & BOEMER, F. (2021). Newborn Screening of Duchenne Muscular Dystrophy Specifically Targeting Deletions Amenable to Exon-skipping Therapy [Poster presentation]. European Human Genetics Conference - ESHG. |
 | Dangouloff, T., Servais, L., & Hiligsmann, M. (2020). SMA: REGISTRIES, BIOMARKERS & OUTCOME MEASURES: P.187 Systematic literature review of the economic burden and economic evaluations in spinal muscular atrophy. Neuromuscular Disorders. doi:10.1016/j.nmd.2020.08.189 Peer Reviewed verified by ORBi |
 | Dangouloff, T., Servais, L., & Hiligsmann, M. (2020). SMA: REGISTRIES, BIOMARKERS & OUTCOME MEASURES: P.191 Preliminary data for the cost-effectiveness assessment of the newborn screening for SMA in Belgium. Neuromuscular Disorders. doi:10.1016/j.nmd.2020.08.193 Peer Reviewed verified by ORBi |
 | Dangouloff, T., BOEMER, F., CABERG, J.-H., & Servais, L. (2020). Correspondence on: “Discrepancy in Spinal Muscular Atrophy Incidence findings in newborn screening programs: the influence of carrier screening?” by Kay et al. Genetics in Medicine. doi:10.1038/s41436-020-0887-1 Peer Reviewed verified by ORBi |
 | Dangouloff, T., Burghes, A., Bertini, E., BOEMER, F., Hiligsmann, M., Mueller-Felber, W., Tiziano, F. D., Young, P., Germanenko, O., De Lemus, M., Ouillade, L., Rucinski, K., Stephenson, K., Farwell, W., Gorni, K., Hjort, M., Kausar, I., Tizzano, E. F., & Servais, L. (January 2020). 244th ENMC International Workshop: Newborn screening in Spinal Muscular Atrophy May 10-12, 2019, Hoofdorp, The Netherlands. Neuromuscular Disorders, 30 (1), 93-103. doi:10.1016/j.nmd.2019.11.002 Peer Reviewed verified by ORBi |
 | Dangouloff, T., BOEMER, F., DIDEBERG, V., CABERG, J.-H., & Servais, L. (2020). Reader response: Discrepancy in redetermination of SMN2 copy numbers in children with SMA [letter to the editor]. Neurology. doi:10.1212/WNL.0000000000009907 Peer Reviewed verified by ORBi |
 | BOEMER, F., CABERG, J.-H., DIDEBERG, V., BECKERS, P., Marie, S., Marcelis, L., Bours, V., Dangouloff, T., & Servais, L. (September 2019). (S)un (M)ay (A)rise on SMA : l'espoir d'une region sans amyotrophie spinale. Revue Médicale de Liège, 74 (9), 461-464. Peer reviewed |
 | Daron, A., DELSTANCHE, S., Dangouloff, T., & Servais, L. (February 2019). Amyotrophie spinale infantile (R)évolution thérapeutique. Revue Médicale de Liège, 74 (2), 82-85. |
 | Boemer, F., CABERG, J.-H., Dideberg, V., DARDENNE, D., Bours, V., Hiligsmann, M., Dangouloff, T., & Servais, L. (2019). Newborn screening for SMA in Southern Belgium. Neuromuscular Disorders. doi:10.1016/j.nmd.2019.02.003 Peer Reviewed verified by ORBi |
 | Dangouloff, T., BOEMER, F., CABERG, J.-H., DIFIORE, S., BECKERS, P., MARIE, S., MARCELIS, L., & Servais, L. (2019). Reducing the diagnosis time of neonatal screening by optimizing the screening process: the southern Belgian experience. Neuromuscular Disorders, 29, 132. doi:10.1016/j.nmd.2019.06.339 Peer Reviewed verified by ORBi |
 | Dangouloff, T., & Servais, L. (2019). Clinical Evidence Supporting Early Treatment Of Patients With Spinal Muscular Atrophy: Current Perspectives. Therapeutics and Clinical Risk Management, 15, 1153-1161. doi:10.2147/TCRM.S172291 Peer Reviewed verified by ORBi |
 | Dangouloff, T., Hiligsmann, M., CABERG, J.-H., BOEMER, F., & Servais, L. (2018). Development of a decision-analytic model for the economic evaluation of newborn screening for spinal muscular atrophy. Neuromuscular Disorders, 28 (S29–S146), 59. doi:10.1016/j.nmd.2018.06.125 Peer Reviewed verified by ORBi |
